Relling MV - Search Results

1

PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5.

Schuetz EG, Relling MV, Kishi S, Yang W, Das S, Chen P, Cook EH, Rosner GL, Pui CH, Blanco JG, Edick MJ, Hancock ML, Winick NJ, Dervieux T, Amylon MD, Bash RO, Behm FG, Camitta BM, Raimondi SC, Goh BC, Lee SC, Wang LZ, Fan L, Guo JY, Lamba J, Lim R, Lim HL, Ong AB, Lee HS, Kuehl P, Zhang J, Lin Y, Assem M, Schuetz J, Watkins PB, Daly A, Wrighton SA, Hall SD, Maurel P, Brimer C, Yasuda K, Venkataramanan R, Strom S, Thummel K, Boguski MS. Schuetz EG, et al. Among authors: relling mv. Pharmacol Rev. 2004 Jun;56(2):159. doi: 10.1124/pr.56.2.1. Pharmacol Rev. 2004. PMID: 15169924 No abstract available.

2

Variability in teniposide plasma protein binding is correlated with serum albumin concentrations.

Petros WP, Rodman JH, Relling MV, Christensen M, Pui CH, Rivera GK, Evans WE. Petros WP, et al. Among authors: relling mv. Pharmacotherapy. 1992;12(4):273-7. Pharmacotherapy. 1992. PMID: 1518726

3

Human cytochrome P450 metabolism of teniposide and etoposide.

Relling MV, Evans R, Dass C, Desiderio DM, Nemec J. Relling MV, et al. J Pharmacol Exp Ther. 1992 May;261(2):491-6. J Pharmacol Exp Ther. 1992. PMID: 1578365

4

Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemia.

Evans WE, Rodman JH, Relling MV, Petros WP, Stewart CF, Pui CH, Rivera GK. Evans WE, et al. Among authors: relling mv. J Pharmacol Exp Ther. 1992 Jan;260(1):71-7. J Pharmacol Exp Ther. 1992. PMID: 1731053

5

Increased teniposide clearance with concomitant anticonvulsant therapy.

Baker DK, Relling MV, Pui CH, Christensen ML, Evans WE, Rodman JH. Baker DK, et al. Among authors: relling mv. J Clin Oncol. 1992 Feb;10(2):311-5. doi: 10.1200/JCO.1992.10.2.311. J Clin Oncol. 1992. PMID: 1732431

6

Individualized dosages of chemotherapy as a strategy to improve response for acute lymphocytic leukemia.

Evans WE, Rodman J, Relling MV, Crom WR, Rivera GK, Crist WM, Pui CH. Evans WE, et al. Among authors: relling mv. Semin Hematol. 1991 Jul;28(3 Suppl 4):15-21. Semin Hematol. 1991. PMID: 1780747 Review. No abstract available.

7

Clinical and biological characteristics of acute lymphocytic leukemia in children with Down syndrome.

Kalwinsky DK, Raimondi SC, Bunin NJ, Fairclough D, Pui CH, Relling MV, Ribeiro R, Rivera GK. Kalwinsky DK, et al. Among authors: relling mv. Am J Med Genet Suppl. 1990;7:267-71. doi: 10.1002/ajmg.1320370753. Am J Med Genet Suppl. 1990. PMID: 2149960

8

Pharmacokinetics and toxicity of methotrexate in children with Down syndrome and acute lymphocytic leukemia.

Garré ML, Relling MV, Kalwinsky D, Dodge R, Crom WR, Abromowitch M, Pui CH, Evans WE. Garré ML, et al. Among authors: relling mv. J Pediatr. 1987 Oct;111(4):606-12. doi: 10.1016/s0022-3476(87)80131-2. J Pediatr. 1987. PMID: 2958611

9

Clinical pharmacodynamic studies of high-dose methotrexate in acute lymphocytic leukemia.

Evans WE, Abromowitch M, Crom WR, Relling MV, Bowman WP, Pui CH, Ochs J, Dodge R. Evans WE, et al. Among authors: relling mv. NCI Monogr. 1987;(5):81-5. NCI Monogr. 1987. PMID: 3481040 Clinical Trial.

10

Variability in human cytochrome P450 paclitaxel metabolism.

Sonnichsen DS, Liu Q, Schuetz EG, Schuetz JD, Pappo A, Relling MV. Sonnichsen DS, et al. Among authors: relling mv. J Pharmacol Exp Ther. 1995 Nov;275(2):566-75. J Pharmacol Exp Ther. 1995. PMID: 7473140

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

466 results

Search Page

Filters